Clinics (Jan 2012)

Assessing the benefits of rosiglitazone in women with polycystic ovary syndrome through its effects on insulin-like growth factor 1, insulin-like growth factor-binding protein-3 and insulin resistance: a pilot study

  • José Gomes Batista,
  • José Maria Soares-Jr,
  • Carla Cristina Maganhin,
  • Ricardo Santos Simões,
  • Geraldez Tomaz,
  • Edmund Chada Baracat

DOI
https://doi.org/10.6061/clinics/2012(03)14
Journal volume & issue
Vol. 67, no. 3
pp. 283 – 287

Abstract

Read online

No abstracts available.